These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11715394)

  • 21. Thalidomide.
    Radomsky CL; Levine N
    Dermatol Clin; 2001 Jan; 19(1):87-103. PubMed ID: 11155589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
    Rosen T; Doherty C
    Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morpheaform sarcoidosis.
    Ginarte M; Zulaica A; Toribio J
    Acta Derm Venereol; 2006; 86(3):264-5. PubMed ID: 16710595
    [No Abstract]   [Full Text] [Related]  

  • 24. Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis.
    Brechtel B; Haas N; Henz BM; Kolde G
    Br J Dermatol; 1996 Aug; 135(2):307-9. PubMed ID: 8881681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug survival of thalidomide for dermatological conditions: A single-centre review.
    Arasu A; Lee S; Chian Yeoh A; Ross G
    Australas J Dermatol; 2021 Feb; 62(1):e107-e109. PubMed ID: 32627846
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cutaneous sarcoidosis. Treatment with thalidomide].
    Barriere H
    Presse Med; 1983 Apr; 12(15):963. PubMed ID: 6221259
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous sarcoidosis: a dermatologic masquerader.
    Katta R
    Am Fam Physician; 2002 Apr; 65(8):1581-4. PubMed ID: 11989634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide experience of a major Australian teaching hospital.
    Crouch RB; Foley PA; Ng JC; Baker CS
    Australas J Dermatol; 2002 Nov; 43(4):278-84. PubMed ID: 12423435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous sarcoidosis therapy updated.
    Badgwell C; Rosen T
    J Am Acad Dermatol; 2007 Jan; 56(1):69-83. PubMed ID: 17190623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide for dermatology: a review of clinical uses and adverse effects.
    Faver IR; Guerra SG; Su WP; el-Azhary R
    Int J Dermatol; 2005 Jan; 44(1):61-7. PubMed ID: 15663665
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of childhood sarcoidosis.
    Hunt SJ; O'toole E; Philips W; Hardman C; Wakelin SH; Walters S
    Clin Exp Dermatol; 2002 Sep; 27(6):448-50. PubMed ID: 12372081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methotrexate for the treatment of patients with chronic cutaneous sarcoidosis: 4 cases].
    Gary A; Modeste AB; Richard C; Jubert C; Majour F; Nouvet G; Remond B; Joly P
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):659-62. PubMed ID: 16230915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: single-center retrospective study of 9 patients.
    Sené T; Juillard C; Rybojad M; Cordoliani F; Lebbé C; Morel P; Tazi A; Guibal F
    J Am Acad Dermatol; 2012 Feb; 66(2):328-32. PubMed ID: 22243729
    [No Abstract]   [Full Text] [Related]  

  • 34. Thalidomide in leprosy and some dermatological conditions--a review.
    Parikh DA; Maniar JK; Ganapati R
    Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis.
    Baughman RP; Judson MA; Ingledue R; Craft NL; Lower EE
    Arch Dermatol; 2012 Feb; 148(2):262-4. PubMed ID: 22004880
    [No Abstract]   [Full Text] [Related]  

  • 36. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
    Mallbris L; Ljungberg A; Hedblad MA; Larsson P; Ståhle-Bäckdahl M
    J Am Acad Dermatol; 2003 Feb; 48(2):290-3. PubMed ID: 12582407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Fumaderm
    Rolls S; Porter W
    Clin Exp Dermatol; 2018 Jul; 43(5):611-613. PubMed ID: 29756252
    [No Abstract]   [Full Text] [Related]  

  • 38. Generalized atrophic sarcoidosis with ulcerations.
    Hruza GJ; Kerdel FA
    Arch Dermatol; 1986 Mar; 122(3):320-2. PubMed ID: 3954396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New indications for thalidomide?].
    Tuinmann G; Hegewisch-Becker S; Hossfeld DK
    Dtsch Med Wochenschr; 2001 Oct; 126(42):1178-82. PubMed ID: 11607859
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
    Kouba DJ; Mimouni D; Rencic A; Nousari HC
    Br J Dermatol; 2003 Jan; 148(1):147-8. PubMed ID: 12534610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.